Skip to content

Study · Animal study (in vivo) · rat · 2020

17 results

Cerebrolysin enhances spinal cord conduction and reduces blood-spinal cord barrier breakdown, edema formation, immediate early gene expression and cord pathology after injury.

Sahib S, Sharma A, Menon PK, Muresanu DF, Castellani RJ, Nozari A, Lafuente JV, Bryukhovetskiy I, Tian ZR, Patnaik R, Buzoianu AD, Wiklund L, Sharma HS

Progress in brain research12 Nov 2020Cited by 15 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study17

7 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In rats with spinal cord injury, Cerebrolysin pretreatment prevented MNP amplitude loss and increased amplitude above the pre-injury level.

    In plain wordsIn rats with spinal cord injury, Cerebrolysin pretreatment preserved signal amplitude and increased it above the pre-injury level.

    Outcome
    IncreaseMNP amplitude with CBL pretreatment
    Study

    ratn: not reported in source

    Spinal cord injury
    Comparator
    Pre-injury level
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    5mL/kg · intravenousAs given in this study (rat).

    Source sentences

    Summary
    Pretreatment with either cerebrolysin (CBL 5mL/kg, i.v. 30min before) alone or TiO2 nanowired delivery of cerebrolysin (NWCBL 2.5mL/kg, i.v.) prevented the loss of MNP amplitude and even enhanced further from the pre-injury level after SCI without affecting latencies.
    1 context sentence
    Summary · context
    SCEP is recorded from epidural space over rat spinal cord T9 and T12 segments after peripheral nerves stimulation.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In rats with spinal cord injury, Cerebrolysin pretreatment did not affect SCEP latencies.

    In plain wordsIn rats with spinal cord injury, Cerebrolysin pretreatment did not affect spinal signal latencies.

    Outcome
    No significant changeSCEP latencies with CBL pretreatment
    Study

    ratn: not reported in source

    Spinal cord injury
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    5mL/kg · intravenousAs given in this study (rat).

    Source sentences

    Summary
    Pretreatment with either cerebrolysin (CBL 5mL/kg, i.v. 30min before) alone or TiO2 nanowired delivery of cerebrolysin (NWCBL 2.5mL/kg, i.v.) prevented the loss of MNP amplitude and even enhanced further from the pre-injury level after SCI without affecting latencies.
    1 context sentence
    Summary · context
    SCEP is recorded from epidural space over rat spinal cord T9 and T12 segments after peripheral nerves stimulation.
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In rats with spinal cord injury, Cerebrolysin pretreatment significantly reduced edema at the reported assessment.

    In plain wordsIn rats with spinal cord injury, Cerebrolysin pretreatment significantly reduced swelling.

    Outcome
    DecreaseEdema with CBL pretreatment
    Study

    ratn: not reported in source

    Spinal cord injury
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    5mL/kg · intravenousAs given in this study (rat).

    Source sentences

    Summary
    At 5h, SCI induced edema, BSCB breakdown, and cell injuries were significantly reduced by CBL and NWCBL pretreatment.
    2 context sentences
    Summary · context
    Pretreatment with either cerebrolysin (CBL 5mL/kg, i.v. 30min before) alone or TiO2 nanowired delivery of cerebrolysin (NWCBL 2.5mL/kg, i.v.) prevented the loss of MNP amplitude and even enhanced further from the pre-injury level after SCI without affecting latencies.
    Summary · context
    SCEP is recorded from epidural space over rat spinal cord T9 and T12 segments after peripheral nerves stimulation.
  4. 04AnimalAnimal study (in vivo)Efficacy outcome

    In rats with spinal cord injury, Cerebrolysin pretreatment significantly reduced blood-spinal cord barrier breakdown.

    In plain wordsIn rats with spinal cord injury, Cerebrolysin pretreatment significantly reduced blood-spinal cord barrier damage.

    Outcome
    DecreaseBlood-spinal cord barrier breakdown with CBL pretreatment
    Study

    ratn: not reported in source

    Spinal cord injury
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    5mL/kg · intravenousAs given in this study (rat).

    Source sentences

    Summary
    At 5h, SCI induced edema, BSCB breakdown, and cell injuries were significantly reduced by CBL and NWCBL pretreatment.
    2 context sentences
    Summary · context
    Pretreatment with either cerebrolysin (CBL 5mL/kg, i.v. 30min before) alone or TiO2 nanowired delivery of cerebrolysin (NWCBL 2.5mL/kg, i.v.) prevented the loss of MNP amplitude and even enhanced further from the pre-injury level after SCI without affecting latencies.
    Summary · context
    SCEP is recorded from epidural space over rat spinal cord T9 and T12 segments after peripheral nerves stimulation.
  5. 05AnimalAnimal study (in vivo)Efficacy outcome

    In rats with spinal cord injury, Cerebrolysin pretreatment significantly reduced cell injuries.

    In plain wordsIn rats with spinal cord injury, Cerebrolysin pretreatment significantly reduced cell injuries.

    Outcome
    DecreaseCell injuries with CBL pretreatment
    Study

    ratn: not reported in source

    Spinal cord injury
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    5mL/kg · intravenousAs given in this study (rat).

    Source sentences

    Summary
    At 5h, SCI induced edema, BSCB breakdown, and cell injuries were significantly reduced by CBL and NWCBL pretreatment.
    2 context sentences
    Summary · context
    Pretreatment with either cerebrolysin (CBL 5mL/kg, i.v. 30min before) alone or TiO2 nanowired delivery of cerebrolysin (NWCBL 2.5mL/kg, i.v.) prevented the loss of MNP amplitude and even enhanced further from the pre-injury level after SCI without affecting latencies.
    Summary · context
    SCEP is recorded from epidural space over rat spinal cord T9 and T12 segments after peripheral nerves stimulation.
  6. 06AnimalAnimal study (in vivo)Mechanism

    In rats with spinal cord injury, Cerebrolysin considerably reduced c-fos expression compared with untreated injury.

    In plain wordsIn rats with spinal cord injury, Cerebrolysin reduced c-fos expression compared with untreated injury.

    Outcome
    Decreasec-fos expression with CBL
    Study

    ratn: not reported in source

    Spinal cord injury
    Comparator
    Untreated spinal cord injury
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition
    Studied dose
    5mL/kg · intravenousAs given in this study (rat).

    Source sentences

    Summary
    Moreover, expressions of c-fos and c-jun genes that are prominent at 5h in untreated SCI are also considerably reduced by CBL and NWCBL treatment.
    2 context sentences
    Summary · context
    Pretreatment with either cerebrolysin (CBL 5mL/kg, i.v. 30min before) alone or TiO2 nanowired delivery of cerebrolysin (NWCBL 2.5mL/kg, i.v.) prevented the loss of MNP amplitude and even enhanced further from the pre-injury level after SCI without affecting latencies.
    Summary · context
    SCEP is recorded from epidural space over rat spinal cord T9 and T12 segments after peripheral nerves stimulation.
  7. 07AnimalAnimal study (in vivo)Mechanism

    In rats with spinal cord injury, Cerebrolysin considerably reduced c-jun expression compared with untreated injury.

    In plain wordsIn rats with spinal cord injury, Cerebrolysin reduced c-jun expression compared with untreated injury.

    Outcome
    Decreasec-jun expression with CBL
    Study

    ratn: not reported in source

    Spinal cord injury
    Comparator
    Untreated spinal cord injury
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition
    Studied dose
    5mL/kg · intravenousAs given in this study (rat).

    Source sentences

    Summary
    Moreover, expressions of c-fos and c-jun genes that are prominent at 5h in untreated SCI are also considerably reduced by CBL and NWCBL treatment.
    2 context sentences
    Summary · context
    Pretreatment with either cerebrolysin (CBL 5mL/kg, i.v. 30min before) alone or TiO2 nanowired delivery of cerebrolysin (NWCBL 2.5mL/kg, i.v.) prevented the loss of MNP amplitude and even enhanced further from the pre-injury level after SCI without affecting latencies.
    Summary · context
    SCEP is recorded from epidural space over rat spinal cord T9 and T12 segments after peripheral nerves stimulation.

Studies that did not test the peptide alone10

In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cerebrolysin.

  1. 08AnimalNot a test of Cerebrolysin aloneAnimal study (in vivo)Efficacy outcome

    In rats with spinal cord injury, nanowired Cerebrolysin pretreatment prevented MNP amplitude loss and increased amplitude above the pre-injury level.

    In plain wordsIn rats with spinal cord injury, nanowired Cerebrolysin pretreatment preserved signal amplitude and increased it above the pre-injury level.

    Outcome
    IncreaseMNP amplitude with NWCBL pretreatment
    Study

    ratn: not reported in source

    Spinal cord injury
    Comparator
    Pre-injury level
    Outcome group
    Neuroprotection · Nervous system and cognition

    Source sentences

    Summary
    Pretreatment with either cerebrolysin (CBL 5mL/kg, i.v. 30min before) alone or TiO2 nanowired delivery of cerebrolysin (NWCBL 2.5mL/kg, i.v.) prevented the loss of MNP amplitude and even enhanced further from the pre-injury level after SCI without affecting latencies.
    1 context sentence
    Summary · context
    SCEP is recorded from epidural space over rat spinal cord T9 and T12 segments after peripheral nerves stimulation.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  2. 09AnimalNot a test of Cerebrolysin aloneAnimal study (in vivo)Efficacy outcome

    In rats with spinal cord injury, nanowired Cerebrolysin pretreatment did not affect SCEP latencies.

    In plain wordsIn rats with spinal cord injury, nanowired Cerebrolysin pretreatment did not affect spinal signal latencies.

    Outcome
    No significant changeSCEP latencies with NWCBL pretreatment
    Study

    ratn: not reported in source

    Spinal cord injury
    Outcome group
    Neuroprotection · Nervous system and cognition

    Source sentences

    Summary
    Pretreatment with either cerebrolysin (CBL 5mL/kg, i.v. 30min before) alone or TiO2 nanowired delivery of cerebrolysin (NWCBL 2.5mL/kg, i.v.) prevented the loss of MNP amplitude and even enhanced further from the pre-injury level after SCI without affecting latencies.
    1 context sentence
    Summary · context
    SCEP is recorded from epidural space over rat spinal cord T9 and T12 segments after peripheral nerves stimulation.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  3. 10AnimalNot a test of Cerebrolysin aloneAnimal study (in vivo)Efficacy outcome

    In rats with spinal cord injury, nanowired Cerebrolysin pretreatment significantly reduced edema at the reported assessment.

    In plain wordsIn rats with spinal cord injury, nanowired Cerebrolysin pretreatment significantly reduced swelling.

    Outcome
    DecreaseEdema with NWCBL pretreatment
    Study

    ratn: not reported in source

    Spinal cord injury
    Outcome group
    Neuroprotection · Nervous system and cognition

    Source sentences

    Summary
    At 5h, SCI induced edema, BSCB breakdown, and cell injuries were significantly reduced by CBL and NWCBL pretreatment.
    2 context sentences
    Summary · context
    Pretreatment with either cerebrolysin (CBL 5mL/kg, i.v. 30min before) alone or TiO2 nanowired delivery of cerebrolysin (NWCBL 2.5mL/kg, i.v.) prevented the loss of MNP amplitude and even enhanced further from the pre-injury level after SCI without affecting latencies.
    Summary · context
    SCEP is recorded from epidural space over rat spinal cord T9 and T12 segments after peripheral nerves stimulation.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  4. 11AnimalNot a test of Cerebrolysin aloneAnimal study (in vivo)Efficacy outcome

    In rats with spinal cord injury, nanowired Cerebrolysin pretreatment significantly reduced blood-spinal cord barrier breakdown.

    In plain wordsIn rats with spinal cord injury, nanowired Cerebrolysin pretreatment significantly reduced blood-spinal cord barrier damage.

    Outcome
    DecreaseBlood-spinal cord barrier breakdown with NWCBL pretreatment
    Study

    ratn: not reported in source

    Spinal cord injury
    Outcome group
    Neuroprotection · Nervous system and cognition

    Source sentences

    Summary
    At 5h, SCI induced edema, BSCB breakdown, and cell injuries were significantly reduced by CBL and NWCBL pretreatment.
    2 context sentences
    Summary · context
    Pretreatment with either cerebrolysin (CBL 5mL/kg, i.v. 30min before) alone or TiO2 nanowired delivery of cerebrolysin (NWCBL 2.5mL/kg, i.v.) prevented the loss of MNP amplitude and even enhanced further from the pre-injury level after SCI without affecting latencies.
    Summary · context
    SCEP is recorded from epidural space over rat spinal cord T9 and T12 segments after peripheral nerves stimulation.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  5. 12AnimalNot a test of Cerebrolysin aloneAnimal study (in vivo)Efficacy outcome

    In rats with spinal cord injury, nanowired Cerebrolysin pretreatment significantly reduced cell injuries.

    In plain wordsIn rats with spinal cord injury, nanowired Cerebrolysin pretreatment significantly reduced cell injuries.

    Outcome
    DecreaseCell injuries with NWCBL pretreatment
    Study

    ratn: not reported in source

    Spinal cord injury
    Outcome group
    Neuroprotection · Nervous system and cognition

    Source sentences

    Summary
    At 5h, SCI induced edema, BSCB breakdown, and cell injuries were significantly reduced by CBL and NWCBL pretreatment.
    2 context sentences
    Summary · context
    Pretreatment with either cerebrolysin (CBL 5mL/kg, i.v. 30min before) alone or TiO2 nanowired delivery of cerebrolysin (NWCBL 2.5mL/kg, i.v.) prevented the loss of MNP amplitude and even enhanced further from the pre-injury level after SCI without affecting latencies.
    Summary · context
    SCEP is recorded from epidural space over rat spinal cord T9 and T12 segments after peripheral nerves stimulation.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  6. 13AnimalNot a test of Cerebrolysin aloneAnimal study (in vivo)Efficacy outcome

    In rats with spinal cord injury, nanowired Cerebrolysin delivered after injury retained a prominent protective effect on SCEP.

    In plain wordsIn rats with spinal cord injury, nanowired Cerebrolysin given after injury retained a prominent protective effect on spinal signals.

    Outcome
    IncreaseSCEP effect with post-injury NWCBL
    Study

    ratn: not reported in source

    Spinal cord injury
    Outcome group
    Neuroprotection · Nervous system and cognition

    Source sentences

    Summary
    Interestingly this effect on SCEP and cord pathology was still prominent when the NWCBL was delivered 2min after SCI.
    1 context sentence
    Summary · context
    SCEP is recorded from epidural space over rat spinal cord T9 and T12 segments after peripheral nerves stimulation.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  7. 14AnimalNot a test of Cerebrolysin aloneAnimal study (in vivo)Efficacy outcome

    In rats with spinal cord injury, nanowired Cerebrolysin delivered after injury retained a prominent protective effect on cord pathology.

    In plain wordsIn rats with spinal cord injury, nanowired Cerebrolysin given after injury retained a prominent protective effect on spinal cord damage.

    Outcome
    DecreaseCord pathology with post-injury NWCBL
    Study

    ratn: not reported in source

    Spinal cord injury
    Outcome group
    Neuroprotection · Nervous system and cognition

    Source sentences

    Summary
    Interestingly this effect on SCEP and cord pathology was still prominent when the NWCBL was delivered 2min after SCI.
    1 context sentence
    Summary · context
    SCEP is recorded from epidural space over rat spinal cord T9 and T12 segments after peripheral nerves stimulation.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  8. 15AnimalNot a test of Cerebrolysin aloneAnimal study (in vivo)Mechanism

    In rats with spinal cord injury, nanowired Cerebrolysin considerably reduced c-fos expression compared with untreated injury.

    In plain wordsIn rats with spinal cord injury, nanowired Cerebrolysin reduced c-fos expression compared with untreated injury.

    Outcome
    Decreasec-fos expression with NWCBL
    Study

    ratn: not reported in source

    Spinal cord injury
    Comparator
    Untreated spinal cord injury
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition

    Source sentences

    Summary
    Moreover, expressions of c-fos and c-jun genes that are prominent at 5h in untreated SCI are also considerably reduced by CBL and NWCBL treatment.
    2 context sentences
    Summary · context
    Pretreatment with either cerebrolysin (CBL 5mL/kg, i.v. 30min before) alone or TiO2 nanowired delivery of cerebrolysin (NWCBL 2.5mL/kg, i.v.) prevented the loss of MNP amplitude and even enhanced further from the pre-injury level after SCI without affecting latencies.
    Summary · context
    SCEP is recorded from epidural space over rat spinal cord T9 and T12 segments after peripheral nerves stimulation.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  9. 16AnimalNot a test of Cerebrolysin aloneAnimal study (in vivo)Mechanism

    In rats with spinal cord injury, nanowired Cerebrolysin considerably reduced c-jun expression compared with untreated injury.

    In plain wordsIn rats with spinal cord injury, nanowired Cerebrolysin reduced c-jun expression compared with untreated injury.

    Outcome
    Decreasec-jun expression with NWCBL
    Study

    ratn: not reported in source

    Spinal cord injury
    Comparator
    Untreated spinal cord injury
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition

    Source sentences

    Summary
    Moreover, expressions of c-fos and c-jun genes that are prominent at 5h in untreated SCI are also considerably reduced by CBL and NWCBL treatment.
    2 context sentences
    Summary · context
    Pretreatment with either cerebrolysin (CBL 5mL/kg, i.v. 30min before) alone or TiO2 nanowired delivery of cerebrolysin (NWCBL 2.5mL/kg, i.v.) prevented the loss of MNP amplitude and even enhanced further from the pre-injury level after SCI without affecting latencies.
    Summary · context
    SCEP is recorded from epidural space over rat spinal cord T9 and T12 segments after peripheral nerves stimulation.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  10. 17AnimalNot a test of Cerebrolysin aloneAnimal study (in vivo)Efficacy outcome

    In rats with spinal cord injury, low-dose nanowired Cerebrolysin had superior neuroprotective effects on spinal signals and cord pathology compared with conventional Cerebrolysin.

    In plain wordsIn rats with spinal cord injury, low-dose nanowired Cerebrolysin protected spinal signals and tissue better than conventional Cerebrolysin.

    Outcome
    IncreaseComparative neuroprotection with low-dose nanowired Cerebrolysin
    Study

    ratn: not reported in source

    Spinal cord injury
    Comparator
    Conventional Cerebrolysin
    Outcome group
    Neuroprotection · Nervous system and cognition

    Source sentences

    Summary
    Furthermore, NWCBL in low doses has superior neuroprotective effects on SCEP and cord pathology, not reported earlier.
    2 context sentences
    Summary · context
    Pretreatment with either cerebrolysin (CBL 5mL/kg, i.v. 30min before) alone or TiO2 nanowired delivery of cerebrolysin (NWCBL 2.5mL/kg, i.v.) prevented the loss of MNP amplitude and even enhanced further from the pre-injury level after SCI without affecting latencies.
    Summary · context
    SCEP is recorded from epidural space over rat spinal cord T9 and T12 segments after peripheral nerves stimulation.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.